Metformin and risk of urinary tract infection
Pro Research Analysisby 
Searched over 200M research papers
Metformin and Urinary Tract Infection (UTI) Risk in Type 2 Diabetes
UTI Risk in Metformin Users: Large-Scale Population Studies
Multiple large studies have found that metformin use in patients with type 2 diabetes does not significantly increase the risk of developing urinary tract infections compared to non-users. In a study of over 40,000 patients, the risk of UTI, recurrent UTI, and sepsis was similar between metformin users and nonusers, with adjusted hazard ratios close to 1.0. However, metformin users had a significantly lower risk of death due to UTI or sepsis, especially with longer duration of use . Another study focusing on insulin-treated patients also found no increased risk of UTI with metformin compared to other oral antidiabetic drugs .
Metformin Versus Other Diabetes Medications and UTI Risk
When comparing metformin to other diabetes medications, such as sodium-glucose cotransporter-2 inhibitors (SGLT2i), dipeptidyl peptidase-4 inhibitors (DPP-4i), and sulfonylureas, the evidence is consistent. Studies show that SGLT2 inhibitors are associated with a higher risk of genital infections, but not a significantly higher risk of UTIs compared to metformin or other agents 68. In fact, some studies found no significant difference in UTI risk between SGLT2i and other drug classes, including metformin, DPP-4i, and sulfonylureas 2347. One study did note a higher leukocyte count in urine (a marker for infection) in SGLT2i users compared to metformin, suggesting a possible trend toward higher UTI susceptibility with SGLT2i, but not with metformin .
Metformin’s Potential Protective Effects
Beyond not increasing UTI risk, metformin may actually strengthen the body’s defense against urinary tract infections. Laboratory research has shown that metformin can enhance the innate immune response of uroepithelial cells, increasing the production of antimicrobial peptides and proinflammatory cytokines that help fight off E. coli, the most common cause of UTIs . This immune-boosting effect could contribute to the observed lower risk of death from UTI or sepsis in metformin users .
Metformin and Lower Urinary Tract Symptoms
In addition to infection risk, metformin use has been linked to a lower risk of developing lower urinary tract symptoms and benign prostatic hyperplasia (BPH) in men with type 2 diabetes. The risk reduction was more pronounced with longer duration and higher cumulative doses of metformin .
Conclusion
Current research shows that metformin does not increase the risk of urinary tract infections in patients with type 2 diabetes and may even lower the risk of severe outcomes from UTI or sepsis. Compared to other diabetes medications, metformin is not associated with a higher UTI risk, and it may offer additional benefits by enhancing the body’s natural defenses against infection and reducing lower urinary tract symptoms.
Sources and full results
Most relevant research papers on this topic